Cargando…

Risk Factors for Seropositivity to Kaposi Sarcoma–Associated Herpesvirus Among Children in Uganda

BACKGROUND: Determinants of Kaposi sarcoma–associated herpesvirus (KSHV) seropositivity among children living in sub-Saharan African populations where infection is endemic are not well understood. Local environmental factors, including other infectious agents, may be key. METHODS: Within the context...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakeham, Katie, Webb, Emily L., Sebina, Ismail, Nalwoga, Angela, Muhangi, Lawrence, Miley, Wendell, Johnston, W. Thomas, Ndibazza, Juliet, Whitby, Denise, Newton, Robert, Elliott, Alison M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707567/
https://www.ncbi.nlm.nih.gov/pubmed/23403859
http://dx.doi.org/10.1097/QAI.0b013e31828a7056
_version_ 1782276513552400384
author Wakeham, Katie
Webb, Emily L.
Sebina, Ismail
Nalwoga, Angela
Muhangi, Lawrence
Miley, Wendell
Johnston, W. Thomas
Ndibazza, Juliet
Whitby, Denise
Newton, Robert
Elliott, Alison M.
author_facet Wakeham, Katie
Webb, Emily L.
Sebina, Ismail
Nalwoga, Angela
Muhangi, Lawrence
Miley, Wendell
Johnston, W. Thomas
Ndibazza, Juliet
Whitby, Denise
Newton, Robert
Elliott, Alison M.
author_sort Wakeham, Katie
collection PubMed
description BACKGROUND: Determinants of Kaposi sarcoma–associated herpesvirus (KSHV) seropositivity among children living in sub-Saharan African populations where infection is endemic are not well understood. Local environmental factors, including other infectious agents, may be key. METHODS: Within the context of a well-characterized birth cohort, we examined associations between various factors and antibodies against KSHV, measured in stored plasma samples from 1823 mother–child pairs in Entebbe, Uganda. RESULTS: Seroprevalence increased with increasing age of the child (P = 0.0003) and was higher among those with KSHV seropositive mothers than in those without (12% vs 9%; odds ratio: 1.4, 95% confidence interval: 1.1 to 2.0). It was also higher among children with HIV infection (29% vs 10%; odds ratio: 3.1, 95% confidence interval: 1.2 to 8.3) or malaria parasitemia (30% vs 10%; odds ratio: 4.1, 95% confidence interval: 2.4 to 7.0) than in children without. These associations were not explained by socioeconomic status. CONCLUSIONS: The finding that KSHV serostatus is associated with malaria parasitemia in children is novel. In a country endemic for KSHV, malaria may be a cofactor for KSHV infection or reactivation among children.
format Online
Article
Text
id pubmed-3707567
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher JAIDS Journal of Acquired Immune Deficiency Syndromes
record_format MEDLINE/PubMed
spelling pubmed-37075672013-07-26 Risk Factors for Seropositivity to Kaposi Sarcoma–Associated Herpesvirus Among Children in Uganda Wakeham, Katie Webb, Emily L. Sebina, Ismail Nalwoga, Angela Muhangi, Lawrence Miley, Wendell Johnston, W. Thomas Ndibazza, Juliet Whitby, Denise Newton, Robert Elliott, Alison M. J Acquir Immune Defic Syndr Epidemiology and Prevention BACKGROUND: Determinants of Kaposi sarcoma–associated herpesvirus (KSHV) seropositivity among children living in sub-Saharan African populations where infection is endemic are not well understood. Local environmental factors, including other infectious agents, may be key. METHODS: Within the context of a well-characterized birth cohort, we examined associations between various factors and antibodies against KSHV, measured in stored plasma samples from 1823 mother–child pairs in Entebbe, Uganda. RESULTS: Seroprevalence increased with increasing age of the child (P = 0.0003) and was higher among those with KSHV seropositive mothers than in those without (12% vs 9%; odds ratio: 1.4, 95% confidence interval: 1.1 to 2.0). It was also higher among children with HIV infection (29% vs 10%; odds ratio: 3.1, 95% confidence interval: 1.2 to 8.3) or malaria parasitemia (30% vs 10%; odds ratio: 4.1, 95% confidence interval: 2.4 to 7.0) than in children without. These associations were not explained by socioeconomic status. CONCLUSIONS: The finding that KSHV serostatus is associated with malaria parasitemia in children is novel. In a country endemic for KSHV, malaria may be a cofactor for KSHV infection or reactivation among children. JAIDS Journal of Acquired Immune Deficiency Syndromes 2013-06-01 2013-04-11 /pmc/articles/PMC3707567/ /pubmed/23403859 http://dx.doi.org/10.1097/QAI.0b013e31828a7056 Text en Copyright © 2013 by Lippincott Williams & Wilkins http://creativecommons.org/licenses/by-nc-nd/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivitives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Epidemiology and Prevention
Wakeham, Katie
Webb, Emily L.
Sebina, Ismail
Nalwoga, Angela
Muhangi, Lawrence
Miley, Wendell
Johnston, W. Thomas
Ndibazza, Juliet
Whitby, Denise
Newton, Robert
Elliott, Alison M.
Risk Factors for Seropositivity to Kaposi Sarcoma–Associated Herpesvirus Among Children in Uganda
title Risk Factors for Seropositivity to Kaposi Sarcoma–Associated Herpesvirus Among Children in Uganda
title_full Risk Factors for Seropositivity to Kaposi Sarcoma–Associated Herpesvirus Among Children in Uganda
title_fullStr Risk Factors for Seropositivity to Kaposi Sarcoma–Associated Herpesvirus Among Children in Uganda
title_full_unstemmed Risk Factors for Seropositivity to Kaposi Sarcoma–Associated Herpesvirus Among Children in Uganda
title_short Risk Factors for Seropositivity to Kaposi Sarcoma–Associated Herpesvirus Among Children in Uganda
title_sort risk factors for seropositivity to kaposi sarcoma–associated herpesvirus among children in uganda
topic Epidemiology and Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707567/
https://www.ncbi.nlm.nih.gov/pubmed/23403859
http://dx.doi.org/10.1097/QAI.0b013e31828a7056
work_keys_str_mv AT wakehamkatie riskfactorsforseropositivitytokaposisarcomaassociatedherpesvirusamongchildreninuganda
AT webbemilyl riskfactorsforseropositivitytokaposisarcomaassociatedherpesvirusamongchildreninuganda
AT sebinaismail riskfactorsforseropositivitytokaposisarcomaassociatedherpesvirusamongchildreninuganda
AT nalwogaangela riskfactorsforseropositivitytokaposisarcomaassociatedherpesvirusamongchildreninuganda
AT muhangilawrence riskfactorsforseropositivitytokaposisarcomaassociatedherpesvirusamongchildreninuganda
AT mileywendell riskfactorsforseropositivitytokaposisarcomaassociatedherpesvirusamongchildreninuganda
AT johnstonwthomas riskfactorsforseropositivitytokaposisarcomaassociatedherpesvirusamongchildreninuganda
AT ndibazzajuliet riskfactorsforseropositivitytokaposisarcomaassociatedherpesvirusamongchildreninuganda
AT whitbydenise riskfactorsforseropositivitytokaposisarcomaassociatedherpesvirusamongchildreninuganda
AT newtonrobert riskfactorsforseropositivitytokaposisarcomaassociatedherpesvirusamongchildreninuganda
AT elliottalisonm riskfactorsforseropositivitytokaposisarcomaassociatedherpesvirusamongchildreninuganda